| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 4.197.273 | 6.621.486 |
| Total Income - EUR | - | - | - | - | - | - | - | 5.487 | 4.231.301 | 6.640.712 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 100.632 | 4.723.360 | 7.001.376 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -95.145 | -492.059 | -360.664 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -95.178 | -496.099 | -360.664 |
| Employees | - | - | - | - | - | - | - | 2 | 7 | 9 |
Check the financial reports for the company - Ameropa Biotech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 3.775 | 11.168 | 7.421 |
| Current Assets | - | - | - | - | - | - | - | 1.087.528 | 6.114.667 | 5.503.432 |
| Inventories | - | - | - | - | - | - | - | 793.731 | 3.050.250 | 1.830.229 |
| Receivables | - | - | - | - | - | - | - | 75.387 | 2.888.737 | 3.476.441 |
| Cash | - | - | - | - | - | - | - | 218.410 | 175.679 | 196.762 |
| Shareholders Funds | - | - | - | - | - | - | - | 205.542 | -291.181 | -651.395 |
| Social Capital | - | - | - | - | - | - | - | 300.720 | 299.808 | 298.132 |
| Debts | - | - | - | - | - | - | - | 885.761 | 6.403.455 | 6.031.568 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4685 - 4685" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Ameropa Biotech S.r.l.